Spongeworthy
This article was originally published in The Gray Sheet
Executive Summary
Allendale Pharmaceuticals recommences sales of the Today Sponge via two Canadian Internet sites. FDA approval is expected within a year after being off the market since 1995 due to quality control systems issues (1"The Gray Sheet" July 17, 2000, p. 11)...
You may also be interested in...
Allendale Pharma's Today Sponge Labeling Passes FDA Panel Muster
Proposed labeling for Allendale Pharmaceuticals' Today sponge adequately conveys the risks associated with use of the female contraceptive albeit with some minor adjustments, FDA's Nonprescription Drugs Advisory Committee concluded at a July 12 meeting.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.